AI-Based Prediction of Homologous Recombination Deficiency (HRD)
Published in Journal of Clinical Oncology, 2022 | Abstract #3019, ASCO This study showcases the use of artificial intelligence (AI)
OneCell Diagnostics is now 1Cell.Ai
Published in Journal of Clinical Oncology, 2022 | Abstract #3019, ASCO This study showcases the use of artificial intelligence (AI)
3rd Indian Cancer Congress 2023 Scientific Session: Driving Innovation in Genomic Profiling and Liquid Biopsy Join leading experts as they
Published in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2022 This study investigates the role of circulating tumor
Watch Now: Dr. Gowhar Shafi at Indian Cancer Congress 2023 Artificial Intelligence Redefining Patient Eligibility for Immunotherapy Hear from Dr.
Watch Now: Mohan Uttarwar at Indian Cancer Congress 2023 AI to Democratize the Adaptation of Precision Oncology: Augmented Intelligence for
Pioneering the Future of Translational Cancer Research At AACR 2024, 1Cell.Ai showcased how AI, live-cell analytics, and multi-omics platforms are
Discover how 1Cell.Ai is advancing precision oncology at the intersection of science and technology Our team is leading the way
Celebrating the Launch of 1Cell.Ai in Europe You’re invited to an exclusive evening of connection, conversation, and innovation as we
Patient: 40 years – Female diagnosed with Renal cell carcinoma Clinical Testing: Treatment Options: The MSH6 gene mutation is indicative
Patient: 66 years – Male diagnosed with High grade urothelial papillary carcinoma Clinical Testing: Treatment Options: In general CDKN2A deficient